Relpax Tablet
Product Images NDC 58151-367

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Relpax (NDC 58151-367). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viatris Specialty Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Relpax (eletriptan Hbr) 20 mg Carton Label (Image 01)

Relpax 20 mg oral tablet packaging label showing a carton design with blue and pink colors. The label displays the proprietary name Relpax, the generic name eletriptan HBr, strength 20 mg, and indicates 6 tablets per card. The labeler is Viatris Specialty LLC. Additional information includes storage instructions, lot/expiration, and barcode details.*

FDA Label Image

Relpax (eletriptan Hbr) 40 mg Carton Label (Image 02)

Packaging label for Relpax 40 mg tablets containing eletriptan hydrobromide. The label shows a card of 6 tablets (one card) and highlights the 40 mg strength. It includes storage instructions and manufacturer information by Viatris Specialty LLC. The label features an image of an orange round tablet marked with 'RELPAX'.*

FDA Label Image

Chemical Structure (Relpax 01)

Chemical structure of eletriptan hydrobromide, showing the molecular arrangement including sulfonyl, indole, and piperidine groups attached to the core structure.*

FDA Label Image

Figure 1 (Relpax 02)

A line chart titled 'Estimated Probability of Initial Headache Response Within 2 Hours' showing the estimated probability of response on the y-axis and time from initial dose in hours on the x-axis. The graph compares response curves over 2 hours for double blind placebo, eletriptan 20 mg, eletriptan 40 mg, and eletriptan 80 mg dosing groups.*

FDA Label Image

Figure 2 (Relpax 03)

A line graph titled 'Estimated Probability of Taking a Second Dose/Other Medication Over the 24 Hours Following the First Dose.' The x-axis represents time from initial dose in hours (0 to 24), and the y-axis shows the probability of a second dose or other medication (0 to 0.9). The graph includes data lines for double blind placebo, eletriptan 20 mg, eletriptan 40 mg, and eletriptan 80 mg, illustrating their respective probabilities over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.